08-09-2026 06:49
via
prnewswire.com
Hoymiles выпускает зарядное устройство постоянного тока V2X мощностью 22 кВт в качестве дополнения к своей интегрированной домашней энергетиче�
ХАНЧЖОУ, Китай, 8 сентября 2026 г. /PRNewswire/ -- Компания Hoymiles выпустила зарядное устройство постоянно
Read more »
PR Public relations news
INVESTOR DEADLINE: UWM Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before October 13, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - UWMC
Acer Reports Revenues for August at NT$30.18 Billion and Year-to-August at NT$214.81 Billion; Both Marking 13-Year Highs for the Same Period
ORVANA ANNOUNCES FIRST GOLD-SILVER DORÉ BAR FROM ITS OXIDES STOCKPILE PROJECT IN BOLIVIA
MAYFAIR GOLD ADVANCES EXPLORATION TARGETS AND PROJECT GEOLOGY AT FENN-GIB
HOLIFERM & ORGANICA COMBINE TO ACCELERATE GLOBAL BIOTECH INNOVATION AND COMMERCIALISATION
Expert.ai Named in the 2026 Gartner® Coolest Vendor Innovations in Agentic AI for Banking, Part 1 Report
Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect
Canaan Inc. Reports Unaudited Second Quarter 2026 Financial Results
Beyond Guesswork: Appier Research Teaches AI to Recognize Its Limits and Choose the Right Reasoning Approach
Aplikace umělé inteligence Guanlan: vyšší přesnost, nižší náklady, chytřejší interakce
IC Optimize Announces Odin and Joins the Cadence Connections Program
Extraordinary in Hand, Effortless in Control HUAWEI Mate XT 2 | ULTIMATE DESIGN Debuts as the First Smartphone to Feature LogicFolding Tau (τ) Chip and Reach Mass Commercialization
AVEX INVESTOR DEADLINE: AEVEX Corp. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - October 20, 2026 Deadline
Ascletis Announces Initiation of Phase I Study in U.S. for Oral Amylin Receptor Peptide Agonist ASC36 for the Treatment of Obesity
Desktop versie